PureTech Health plc (LON:PRTC)
London · Delayed Price · Currency is GBP · Price in GBX 115.00
-1.00 (-0.86%)
Sep 25, 2026, 3:04 PM GMT
PureTech Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.37 | 4.66 | 4.83 | 3.33 | 15.62 | 17.39 | |
Revenue Growth | -0.41% | -3.50% | 44.98% | -78.68% | -10.18% | 47.76% |
Cost of Revenue | 65.43 | 56.46 | 69.23 | 94.98 | 152.43 | 110.47 |
Gross Profit | -59.06 | -51.8 | -64.4 | -91.65 | -136.82 | -93.08 |
Selling, General & Admin | 43.72 | 46.62 | 71.47 | 53.3 | 60.99 | 57.2 |
Operating Expenses | 43.72 | 46.62 | 71.47 | 53.3 | 60.99 | 57.2 |
Operating Income | -102.78 | -98.41 | -135.87 | -144.94 | -197.81 | -150.28 |
Interest Expense | -69.68 | -45.78 | -10.04 | -13.49 | -3.95 | -4.71 |
Interest & Investment Income | 10.31 | 13.05 | 22.67 | 16.01 | 5.8 | 0.21 |
Earnings From Equity Investments | 5.63 | -17.93 | -8.75 | -6.06 | -27.75 | -73.7 |
Currency Exchange Gain (Loss) | 0 | -0.01 | -0.03 | -0.09 | 0.01 | -0.06 |
Other Non Operating Income (Expenses) | 1.09 | 1.33 | -7.15 | 1.74 | 145.19 | 11.2 |
EBT Excluding Unusual Items | -155.44 | -147.75 | -139.16 | -146.82 | -78.5 | -217.34 |
Gain (Loss) on Sale of Investments | 161.29 | 36.93 | 11.08 | 50.19 | -41.53 | 158.39 |
Gain (Loss) on Sale of Assets | - | - | 151.81 | 61.79 | 27.25 | - |
Asset Writedown | -0.11 | -0.11 | -0.23 | -1.26 | - | - |
Other Unusual Items | - | - | 0.27 | - | - | - |
Pretax Income | 5.75 | -110.93 | 23.77 | -36.1 | -92.78 | -58.95 |
Income Tax Expense | 4.32 | -0.84 | -4.01 | 30.53 | -55.72 | 3.76 |
Earnings From Continuing Operations | 1.43 | -110.08 | 27.78 | -66.63 | -37.06 | -62.71 |
Minority Interest in Earnings | 0.68 | 0.35 | 25.73 | 0.93 | -13.29 | 2.15 |
Net Income | 2.11 | -109.74 | 53.51 | -65.7 | -50.35 | -60.56 |
Net Income to Common | 2.11 | -109.74 | 53.51 | -65.7 | -50.35 | -60.56 |
Net Income Growth | -95.83% | - | - | - | - | - |
Shares Outstanding (Basic) | 242 | 241 | 254 | 276 | 285 | 287 |
Shares Outstanding (Diluted) | 245 | 241 | 254 | 276 | 285 | 287 |
Shares Change | 2.26% | -5.37% | -7.91% | -2.97% | -0.64% | -2.14% |
EPS (Basic) | 0.01 | -0.46 | 0.21 | -0.24 | -0.18 | -0.21 |
EPS (Diluted) | 0.01 | -0.46 | 0.21 | -0.24 | -0.18 | -0.21 |
EPS Growth | -96.13% | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -83.64 | -85.14 | -134.38 | -105.99 | -180.97 | -163.85 |
Free Cash Flow Per Share | -0.34 | -0.35 | -0.53 | -0.38 | -0.64 | -0.57 |
Operating Margin | -1614.82% | -2112.34% | -2814.19% | -4352.55% | -1266.53% | -864.29% |
Profit Margin | 33.21% | -2355.42% | 1108.33% | -1972.88% | -322.41% | -348.27% |
Free Cash Flow Margin | -1314.01% | -1827.37% | -2783.35% | -3182.79% | -1158.71% | -942.29% |
EBITDA | -101.25 | -96.83 | -134.06 | -141.99 | -191.96 | -145.93 |
D&A For EBITDA | 1.54 | 1.58 | 1.81 | 2.95 | 5.85 | 4.35 |
EBIT | -102.78 | -98.41 | -135.87 | -144.94 | -197.81 | -150.28 |
Effective Tax Rate | 75.08% | - | - | - | - | - |
Revenue as Reported | 6.37 | 4.66 | 4.83 | 3.33 | 15.62 | 17.39 |